Core Viewpoint - The company has recently obtained an invention patent certificate for the synthesis method of a core product, which signifies a strategic enhancement of its technological capabilities and intellectual property protection [1][2]. Group 1: Patent Acquisition - The company has received an invention patent certificate from the National Intellectual Property Administration of China for a synthesis method of Rhizoma Anemones [1]. - The synthesis method involves using gallic acid and malic acid as raw materials, with concentrated sulfuric acid as a condensation catalyst, achieving a product yield of over 90% and purity of up to 99% [1]. Group 2: Strategic Implications - The acquisition of this patent reflects not only a technological advancement but also a strategic move to strengthen core technologies and lay a foundation for future development [2]. - The company now holds two patents related to the synthesis process of Rhizoma Anemones, which will enhance its core competitiveness in technological innovation and support the development of this key product [2].
吉林省西点药业科技发展股份有限公司关于取得发明专利证书的公告